EPISODE · Jul 10, 2024 · 8 MIN
Unresearched GLP-1 Agonist Practices
from Weight and Healthcare · host Ragen Chastain
As I discuss the issues of GLP-1 agonist and GLP-1/GIP co-agonist weight loss drugs Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound)I’ve been increasingly hearing from people who are engaged in practices with these drugs that are not remotely evidence based. Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe
Embed this episode
NOW PLAYING
Unresearched GLP-1 Agonist Practices
0:00
8:16
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Weight and Healthcare?
This episode is 8 minutes long.
When was this Weight and Healthcare episode published?
This episode was published on July 10, 2024.
Can I download this Weight and Healthcare episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!